#23 Matthew Johnson: The Forefront of Psilocybin, Ecstasy, and Psychedelics as Treatment for Addiction Business, Life, and Ayahuasca with Daniel Cleland

On episode 23 of Business, Life, and Ayahuasca, we are pleased to have a guest that is at the forefront of psychedelic research, Dr. Matthew Johnson. Dr. Matthew Johnson is a professor of psychiatry and behavioral sciences at Johns Hopkins University. In 2014 he developed and published the first research on psychedelic treatment of tobacco addiction. Furthermore Dr. Johnson and colleagues published the largest study of psilocybin in treating cancer distress in 2016. Dr. Matthew Johnson expands upon these topics and many more in this episode  of Business, Life, and Ayahuasca. As always, this episode is brought to you by Soltara Healing Center. 

Connect with Matthew Johnson
Website- https://www.hopkinsmedicine.org/profiles/details/matthew-johnson
Twitter- @Drug_Researcher
 
Connect with Daniel Cleland
Website - http://danielcleland.com/
Instagram - @danielccleland
Facebook - @danielccleland
 
Sign up for my Newsletter: http://danielcleland.com/
 
Subscribe to my YouTube channel: https://www.youtube.com/c/DanielCleland
 
Subscribe to the podcast:
iTunes
Spotify
Google